Tekla Capital Management LLC Incyte Corp Transaction History

Tekla Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $7.39 Million - $9.05 Million	-107,687 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $1.1 Million - $1.45 Million	14,430 Added 15.47%	107,687 $8.75 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $4.79 Million - $5.8 Million	-59,348 Reduced 38.89%	93,257 $8.11 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $14.7 Million - $18.9 Million	-172,448 Reduced 53.05%	152,605 $13.7 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $7.95 Million - $11.7 Million	-107,193 Reduced 24.8%	325,053 $33.8 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $3.1 Million - $4.21 Million	49,016 Added 12.79%	432,246 $31.7 Million
Q4 2019 Feb 13, 2020	SELL	$73.04 - $95.72 $766,920 - $1.01 Million	-10,500 Reduced 2.67%	383,230 $33.5 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $8.53 Million - $10.1 Million	-117,203 Reduced 22.94%	393,730 $29.2 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $1.34 Million - $1.61 Million	-18,200 Reduced 3.44%	510,933 $43.4 Million
Q1 2019 May 14, 2019	SELL	$63.56 - $88.17 $7.39 Million - $10.3 Million	-116,309 Reduced 18.02%	529,133 $45.5 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $3.97 Million - $4.83 Million	-47,833 Reduced 6.9%	645,442 $53.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	693,275	693,275 $87.3 Million

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.